Email: wangc90@cczu.edu.cn
电话：**

王程，海南澄迈人。浙江大学药物制剂专业博士毕业。以第一作者或者通讯作者在Advanced Materials, Theranostics, Advanced Healthcare Materials，Nanoscale，Chemical Communications, Acta Biomaterialia，Carbohydrate Polymers等杂志发表论文。累计已发表SCI收录论文50余篇。受邀成为ACS Nano，Materials Science & Engineering C，Journal of Materials Chemistry B，Biomedicine & Pharmacotherapy，Artificial Cells, Nanomedicine and Biotechnology等杂志审稿人. 被引用次数920次，h-index为19。
研究方向：肿瘤相关生物信息分析和纳米给药系统的构建
1. 基于无定型碳酸钙的复合脂质纳米粒的构建和应用
2. 脂质纳米载体的设计和开发
3. 肿瘤相关生物信息分析
主要工作及教育经历
2008.08-2012.06:中国药科大学（制药工程学士）
2012.08-2015.06:中国药科大学（制药工程硕士）
2015.08-2019.06浙江大学（医学博士）
2020.09-至今：常州大学药学院制药工程系
代表性成果：
(1)Cheng Wang, Shaoqing Chen, Yunxin Wang, Xuerong Liu, Fuqiang Hu, Jihong Sun*, Hong Yuan*, Lipase‐Triggered Water‐Responsive “Pandora's Box” for Cancer Therapy: Toward Induced Neighboring Effect and Enhanced Drug Penetration, Advanced Materials 30(14) (2018) **. (IF:25.809)
(2) Cheng Wang, Fangying Yu, Xuerong Liu, Shaoqing Chen, Rui Wu, Rui Zhao, Fuqiang Hu, Hong Yuan*, Cancer‐Specific Therapy by Artificial Modulation of Intracellular Calcium Concentration, Advanced Healthcare Materials 8 (8) (2019) **. (IF: 7.367)
(3) Cheng Wang, Ziyu Wang, Xin Zhao, Fangying Yu, Yiwu Quan*, Yixiang Cheng*, Hong Yuan*, DOX Loaded Aggregation-induced Emission Active Polymeric Nanoparticles as a Fluorescence Resonance Energy Transfer Traceable Drug Delivery System for Self-indicating Cancer Therapy, Acta Biomaterialia 85 (2019) 218-228. (IF: 7.242)
(4) Xin Zhao^#, Dongyang Tang^#, Ying Wu, Shaoqing Chen*, Cheng Wang*, Artificial cell system for biocompatible gene delivery in cancer therapy, Nanoscale 12(18) (2020) 10189-10195. (IF: 6.970)
(5) Xin Zhao, Ruoyu Shen, Lu Bao, Cheng Wang*, Hong Yuan*, Chitosan derived glycolipid nanoparticles for magnetic resonance imaging guided photodynamic therapy of cancer. Carbohydrate Polymers 245 (1) (2020) 116509. (IF: 7.182)
(6) Jianwei Wang^#, Shan Tao^#, Xiangyu Jin Yanqing Song, Wentao Zhou, Haiya Lou, Rui Zhao, Cheng Wang*, Fuqiang Hu, Hong Yuan*. Calcium Supplement by Tetracycline guided amorphous Calcium Carbonate potentiates Osteoblast promotion for Synergetic Osteoporosis Therapy. Theranostics 10(19) (2020) 8591. (IF: 8.579)
(7) Cheng Wang, Xuerong Liu, Shaoqing Chen, Fuqiang Hu, Jihong Sun*, Hong Yuan*, Facile preparation of phospholipid–amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration, Chemical Communications 54(93) (2018) 13080-13083. (IF: 6.164)
(8) Cheng Wang^#, Min Han^#, Xuerong Liu, Shaoqing Chen, Fuqiang Hu, Jihong Sun*, Hong Yuan*, Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy, International Journal of Nanomedicine 14 (2019) 1503-1517. (IF: 5.242)
(9) Xin Zhao, Dongyang Tang*, Xu Zuo, Tiandong Zhang*, Cheng Wang*, Identification of lncRNA–miRNA–mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant, Journal of Cellular Physiology 234(11) (2019)19886-19894. (IF: 5.546)
(10) Dongyang Tang*, Xin Zhao, Li Zhang, Cheng Wang*, Comprehensive analysis of pseudogene HSPB1P1 and its potential roles in hepatocellular carcinoma, Journal of Cellular Physiology 235(10) (2020) 6515-6527. (IF: 5.546)
(11) Cheng Wang, Shaoqing Chen, Lu Bao, Xuerong Liu, Fuqiang Hu, Hong Yuan*. Size-Controlled Preparation and Behavior Study of Phospholipid–Calcium Carbonate Hybrid Nanoparticles. International Journal of Nanomedicine 15 (2020) 4049-4062. (IF: 5.242)